Subgroup analysis revealed that WHO grade 2 patients did not benefit from radiotherapy regardless of whether they were in the high- or low-PI12 group, possibly due to a failure to adequately consider patient age, extent of tumor resection, IDH, and 1p/19q status, but the limited sample size did not support a more detailed subgroup analysis. The gene discussed is IDH1; the disease is neoplasm.